Jule Harbig
Research Subjects
Jule Harbig has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Bence Sipos
Institute of Pathology, University of Tuebingen, Tuebingen, Germany
2 shared publicationsFlorian Heinzmann
Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany
2 shared publicationsGrégory Doré
Institut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France
2 shared publicationsHien Dang
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
2 shared publications- Lars Zender
Department of Medical Oncology and Pneumology, University Hospital Tuebingen, Tuebingen, Germany
2 shared publications Lisa Hoenicke
Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany
2 shared publications
Latest Publications
- Open Access
- 8 November 2018
- Published by Springer Nature in Nature
- Vol. 564 (7735) , E9
Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer
In this Article, the pCaMIN construct consisted of ‘mouse MYC and mouse NrasG12V’ instead of ‘mouse Myc and human NRASG12V; and the pCAMIA construct consisted of ‘mouse Myc and human AKT1’ instead of ‘mouse Myc and Akt1’ this has been corrected online.
- 8 November 2018
- Published by Springer Nature in Nature
- Vol. 564 (7735) , E9
Open AccessAuthor Correction: Necroptosis microenvironment directs lineage commitment in liver cancer
In this Article, the pCaMIN construct consisted of ‘mouse MYC and mouse NrasG12V’ instead of ‘mouse Myc and human NRASG12V; and the pCAMIA construct consisted of ‘mouse Myc and human AKT1’ instead of ‘mouse Myc and Akt1’ this has been corrected online.
- Top Cited Papers
- 12 September 2018
- Published by Springer Nature in Nature
- Vol. 562 (7725) , 69-75
Necroptosis microenvironment directs lineage commitment in liver cancer
Primary liver cancer represents a major health problem. It comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), which differ markedly with regards to their morphology, metastatic potential and responses to therapy. However, the regulatory molecules and tissue context that commit transformed hepatic cells towards HCC or ICC are largely unknown. Here we show that the hepatic microenvironment epigenetically shapes lineage commitment in mosaic mouse models of liver tumorigenesis. Whereas a necroptosis-associated hepatic cytokine microenvironment determines ICC outgrowth from oncogenically transformed hepatocytes, hepatocytes containing identical oncogenic drivers give rise to HCC if they are surrounded by apoptotic hepatocytes. Epigenome and transcriptome profiling of mouse HCC and ICC singled out Tbx3 and Prdm5 as major microenvironment-dependent and epigenetically regulated lineage-commitment factors, a function that is conserved in humans. Together, our results provide insight into lineage commitment in liver tumorigenesis, and explain molecularly why common liver-damaging risk factors can lead to either HCC or ICC.
- 12 September 2018
- Published by Springer Nature in Nature
- Vol. 562 (7725) , 69-75
Top Cited PapersNecroptosis microenvironment directs lineage commitment in liver cancer
Primary liver cancer represents a major health problem. It comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), which differ markedly with regards to their morphology, metastatic potential and responses to therapy. However, the regulatory molecules and tissue context that commit transformed hepatic cells towards HCC or ICC are largely unknown. Here we show that the hepatic microenvironment epigenetically shapes lineage commitment in mosaic mouse models of liver tumorigenesis. Whereas a necroptosis-associated hepatic cytokine microenvironment determines ICC outgrowth from oncogenically transformed hepatocytes, hepatocytes containing identical oncogenic drivers give rise to HCC if they are surrounded by apoptotic hepatocytes. Epigenome and transcriptome profiling of mouse HCC and ICC singled out Tbx3 and Prdm5 as major microenvironment-dependent and epigenetically regulated lineage-commitment factors, a function that is conserved in humans. Together, our results provide insight into lineage commitment in liver tumorigenesis, and explain molecularly why common liver-damaging risk factors can lead to either HCC or ICC.